SE442748B - Forfarande for framstellning av etrar av klavulansyra - Google Patents

Forfarande for framstellning av etrar av klavulansyra

Info

Publication number
SE442748B
SE442748B SE7704085A SE7704085A SE442748B SE 442748 B SE442748 B SE 442748B SE 7704085 A SE7704085 A SE 7704085A SE 7704085 A SE7704085 A SE 7704085A SE 442748 B SE442748 B SE 442748B
Authority
SE
Sweden
Prior art keywords
ethres
preparing
procedure
clavulanic acid
clavulanic
Prior art date
Application number
SE7704085A
Other languages
English (en)
Other versions
SE7704085L (sv
Inventor
T T Howarth
R J Ponsford
K Luk
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB10082/77A external-priority patent/GB1582864A/en
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of SE7704085L publication Critical patent/SE7704085L/sv
Publication of SE442748B publication Critical patent/SE442748B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7704085A 1977-03-10 1977-04-06 Forfarande for framstellning av etrar av klavulansyra SE442748B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1011677 1977-03-10
GB10082/77A GB1582864A (en) 1977-03-10 1977-03-10 Chemical process for the preparation of clavulanic acid derivatives

Publications (2)

Publication Number Publication Date
SE7704085L SE7704085L (sv) 1978-09-11
SE442748B true SE442748B (sv) 1986-01-27

Family

ID=26247246

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7704085A SE442748B (sv) 1977-03-10 1977-04-06 Forfarande for framstellning av etrar av klavulansyra

Country Status (19)

Country Link
JP (1) JPS53112894A (sv)
AR (1) AR216505A1 (sv)
AT (1) AT359188B (sv)
AU (1) AU519232B2 (sv)
CH (1) CH632760A5 (sv)
DE (1) DE2808116A1 (sv)
DK (1) DK139377A (sv)
ES (1) ES467513A1 (sv)
FI (1) FI65252C (sv)
FR (1) FR2383184A1 (sv)
GR (1) GR64160B (sv)
HK (1) HK15084A (sv)
IE (1) IE46478B1 (sv)
IL (1) IL54078A0 (sv)
KE (1) KE3337A (sv)
MX (1) MX4864E (sv)
NL (1) NL7802596A (sv)
NO (1) NO771106L (sv)
SE (1) SE442748B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002370B1 (en) * 1977-12-02 1983-05-11 Beecham Group Plc A process for the preparation of ether derivatives of clavulanic acid
JPS58187371A (ja) * 1982-04-27 1983-11-01 Nec Corp 印字濃度制御回路
DE3725375A1 (de) * 1987-07-31 1989-02-09 Bayer Ag Stabile oxapenem-3-carbonsaeuren

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1573503A (en) * 1975-12-17 1980-08-28 Glaxo Lab Ltd Clavulanic acid derivatives

Also Published As

Publication number Publication date
ES467513A1 (es) 1979-08-01
FR2383184A1 (fr) 1978-10-06
JPS53112894A (en) 1978-10-02
FI65252B (fi) 1983-12-30
AR216505A1 (es) 1979-12-28
GR64160B (en) 1980-02-05
NL7802596A (nl) 1978-09-12
HK15084A (en) 1984-02-24
FR2383184B1 (sv) 1980-08-29
NO771106L (no) 1978-09-12
FI65252C (fi) 1984-04-10
FI771146A (fi) 1978-09-11
SE7704085L (sv) 1978-09-11
IE780477L (en) 1978-09-10
DK139377A (da) 1978-09-11
KE3337A (en) 1983-11-25
ATA145178A (de) 1980-03-15
AU3384078A (en) 1979-09-06
IE46478B1 (en) 1983-06-29
DE2808116A1 (de) 1978-09-21
IL54078A0 (en) 1978-04-30
AT359188B (de) 1980-10-27
MX4864E (es) 1982-11-10
CH632760A5 (en) 1982-10-29
AU519232B2 (en) 1981-11-19

Similar Documents

Publication Publication Date Title
NO802498L (no) Fremgangsmaate for fremstilling av clavulansyresalter
NO854260L (no) Fremgangsmaate for fremstilling av (d-alfa-amino-(p-hydroksyfenylacetamido)) gruppeholdige cefalosporansyrederivater
SE7813406L (sv) Forfarande for framstellning av implantat
SE7801428L (sv) Forfarande for framstellning av cefemkarbonsyror
NO782484L (no) Fremgangsmaate for fremstilling av sulfobetainer
NO771578L (no) Fremgangsmaate for fremstilling av di-n-propyleddiksyre
SE7803853L (sv) Forfarande for framstellning av estrar av oxalsyra
SE437833B (sv) Forfarande for framstellning av 7-beta-oxiiminoacylcefalosporiner
SE7802609L (sv) Forfarande for framstellning av 1-azaxanton-3-karboxylsyraderivat
FI791562A (fi) Foerfarande foer framstaellning av 4-amino-2-piperidinokinazolinderivat
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
SE440080B (sv) Forfarande for framstellning av klavulansyraderivat
SE7805676L (sv) Nytt forfarande for framstellning av alkaloider av leurosintypen
SE7804808L (sv) Forfarande for diskontinuerlig framstellning av polyamider
SE7706262L (sv) Forfarande for framstellning av kvadratsyra
SE7804261L (sv) Forfarande for framstellning av prostansyraderivat
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
SE442748B (sv) Forfarande for framstellning av etrar av klavulansyra
DK525978A (da) Fremgangsmaade til fremstilling af clavulansyrederivater
SE7811704L (sv) Framstellning av 1-hydrokarbylpyrrol-2-ettiksyraderivat
SE7809202L (sv) Forfarande for framstellning av 2-klorsulfinylazetidin-4-oner
FI783743A (fi) Foerfarande foer framstaellning av 3-di-n-propyl-acetoxi-benzodiazepin-2-oner
NO149774C (no) Fremgangsmaate for fremstilling av et azetidinon
SE7805324L (sv) Forfarande for framstellning av 3-bromftalid